The Science Behind Acellerate GF™
Our research team has confirmed that neurogenic growth factors have a regenerative effect on peripheral nerves that are adversely affected by co-morbidities such as diabetes and HIV. Neurogenic growth factors found in Acellerate GF have a profound effect on the clinical presentation seen in patients suffering from HIV as well as Diabetes associated peripheral neuropathy. Improved sensory perception, proprioception as well as decreased pain are expected clinical outcomes.
Platelet-rich plasma fibrin matrix when combined with collagen has been found to provide a micro-scaffold infrastructure to augment angiogenesis, epithelialization and subsequent wound healing. Acting as a slow-release form of essential growth factors, Acellerate GF can be used for wound optimization. All patients should be screened for adequate vasculature, anemia as well as hypoalbuminemia.
Platelet-rich plasma contains a variety of growth factors that are essential in the healing process of injured or damaged tissue. Acellerate GF is a mixture of platelet-rich as well as platelet-poor plasma which contains a high concentration of growth factors as well as fibrin which is essential in wound healing. The platelets in Acellerate GF are aggregated then activated in a proprietary way to amplify the release of growth factors. This product is indicated for mild to moderate osteoarthritis as well as an array of tendinopathies. Additionally, Acellerate GF is indicated for chronic non-healing wounds and is used as a wound optimizer when administered in a peri-wound fashion. Angiogenic as well as epithelial growth factors are responsible for rapid wound closure.